Fortaleza Asset Management’s Integra LifeSciences IART Stock Holding History

Fortaleza Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$102K	Sell	1,585 -720	-31%	-$44.6K	0.83%	66
2018 Q1	$128K	Hold	2,305	–	–	0.78%	68
2017 Q4	$110K	Hold	2,305	–	–	0.69%	74
2017 Q3	$116K	Hold	2,305	–	–	0.21%	130
2017 Q2	$126K	Hold	2,305	–	–	0.24%	121
2017 Q1	$97K	Buy	+2,305	New	+$98.5K	0.2%	133

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fortaleza Asset Management's IART Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Integra LifeSciences (IART) stake by 31% in Q2 2018, selling an estimated $44.6K and leaving 1,585 shares worth $102K. The position accounts for 0.83% of the portfolio, ranked #66.

Fortaleza Asset Management first reported a position in IART in Q1 2017 and has held it in 6 quarters since. The position peaked at $128K in Q1 2018. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

Fortaleza Asset Management held 1,585 shares of Integra LifeSciences worth $102K as of Q2 2018.
Fortaleza Asset Management sold 720 Integra LifeSciences shares in Q2 2018, an estimated $44.6K.
Integra LifeSciences made up 0.83% of Fortaleza Asset Management's portfolio in Q2 2018, its #66 holding.
Fortaleza Asset Management first reported a position in Integra LifeSciences in Q1 2017 and has held it in 6 quarters since.
Fortaleza Asset Management's Integra LifeSciences position peaked at $128K in Q1 2018.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.